Dr. Bacchetta, a physician-scientist with pediatric immunology expertise, received her medical education at the University of Turin, and her immunological training at DNAX Research Institute. At the San Raffaele-Telethon Scientific Institute, she focused on dissecting the mechanistic basis of primary immune-regulatory diseases to develop gene transfer-based treatments. She is Associate Professor in Pediatrics at Stanford University, and the Sponsor of the Phase 1 gene therapy trial using engineered CD4LVFOXP3 Treg-like cells to treat IPEX patients.